E2 Conjugating
E2 proteins have various individual and redundant roles within the cell and have important roles in target degradation (proteasomal pathways) and target modification for regulatory purposes (non-proteasomal pathways). The biochemical process of Ub/UBL conjugation is initiated by the ATP-dependent E1 enzyme, followed by transfer to the active site cysteine of E2 enzymes.
| E2-603 |
UbcH1 (E2-25K) |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-605 |
GST-UbcH2 (E2-14K) |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-607 |
UbcH2 (E2-14K) |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-608 |
UbcH2, Dominant Negative |
human recombinant |
100 μg |
$180 |
| E2-610 |
His6-UbcH3 (Cdc34) |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-611 |
His6-UbcH3, Dominant Negative |
human recombinant |
100 μg |
$180 |
| E2-612 |
His6-hHR6A |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-613 |
His6-hHR6B |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-615 |
GST-UbcH5a |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-616 |
UbcH5a |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-617 |
GST-UbcH5a, Dominant Negative |
human recombinant |
100 μg |
$180 |
| E2-618 |
UbcH5a, Dominant Negative |
human recombinant |
100 μg |
$180 |
| E2-620 |
GST-UbcH5b |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-622 |
UbcH5b |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-625 |
GST-UbcH5c |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-627 |
UbcH5c |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-630 |
His6-UbcH6 |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-632 |
His6-UbcH6, Dominant Negative |
human recombinant |
100 μg |
$180 |
| E2-640 |
UbcH7 |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-642 |
UbcH7, Dominant Negative |
human recombinant |
100 μg |
$180 |
| E2-643 |
GST-UbcH8 |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-644 |
UbcH8 |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-645 |
UbcH9 |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-646 |
UbcH9, Dominant Negative |
human recombinant |
100 μg |
$180 |
| E2-650 |
His6-UbcH10 |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-652 |
His6-UbcH10, Dominant Negative |
human recombinant |
100 μg |
$180 |
| E2-655 |
GST-UbcH12 |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-656 |
UbcH12 |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-660 |
His6-UbcH13 |
human recombinant |
100 μg |
$200 |
| E2-662 |
His6-Uev1a |
human recombinant |
100 μg |
$200 |
| E2-664 |
His6-UbcH13/Uev1a complex |
human recombinant |
100 μg |
$200 |
| E2-670 |
His6-Apg3p |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-675 |
His6-Ufc1 |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-677 |
His6-Use1 |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-678 |
His6-Ube2E3 |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-679 |
His6-Ube2F |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-680 |
His6-Ube2G2 |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-690 |
His6-Ube2S |
human recombinant |
50 μg 100 μg |
$120 $200 |
| E2-695 |
His6-Ube2T |
human recombinant |
50 μg 100 μg |
$100 $200 |





